Electronic Platform for Diabetic Patients Activation (INSULINCOM)
Hypoglycemia, Hypoglycemia Acute
About this trial
This is an interventional supportive care trial for Hypoglycemia
Eligibility Criteria
Inclusion Criteria:
- Aged over 17 years
- Patients with type 2 diabetes diagnosis
- Patients who start insulin treatment or with intensification of treatment
- Patients who sign informed consent
Exclusion Criteria:
- Patients with type 1 diabetes diagnosis
- Life expectancy less than one year
- Pregnancy
- Patients with dementia
- Patients with treatment different to insulin
- Patients who, in the opinion of the researcher, cannot follow the recommendations of the self-care health education plan.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Intervention
Usual care and usual communication with health professional
They will be trained to use the ti.care platform and will be able to use it as a communication channel for any questions or clarification they require during the time elapsed between routine control visits. This platform will be a complement to the visits, but in no case will it replace them or be used as a diagnostic or therapeutic method. The platform does not have any treatment algorithm and only aims to facilitate communication between the patient at home and the health professional, both the doctor and the nurse educator. It will be used in a preventive and advisory manner for the patient for follow-up. In no case it will be used for emergencies. Daily during working hours from Monday to Friday, health professionals will review patient requests and respond to them.